Search Results - "SEAMAN, H. E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Can symptomatology help in the diagnosis of endometriosis? Findings from a national case–control study—Part 1 by Ballard, KD, Seaman, HE, De Vries, CS, Wright, JT

    “…Objective  To determine the value of patient‐reported symptoms in diagnosing endometriosis. Design  A national case–control study. Setting  Data from the UK…”
    Get full text
    Journal Article
  2. 2

    Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case–control study—Part 2 by Seaman, HE, Ballard, KD, Wright, JT, De Vries, CS

    “…Objective  To investigate whether the increased chances of having a diagnosis of irritable bowel syndrome (IBS) and pelvic inflammatory disease (PID) in women…”
    Get full text
    Journal Article
  3. 3

    Mortality in people with Type 2 diabetes in the UK by Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah-Muthu, S. S., Colhoun, H. M., Lawrenson, R. A.

    Published in Diabetic medicine (01-05-2006)
    “…Aims  Under‐reporting of diabetes on death certificates contributes to the unreliable estimates of mortality as a result of diabetes. The influence of obesity…”
    Get full text
    Journal Article
  4. 4

    Risk of stroke in people with type 2 diabetes in the UK : a study using the General Practice Research Database by MULNIER, H. E, SEAMAN, H. E, RALEIGH, V. S, SOEDAMAH-MUTHU, S. S, COLHOUN, H. M, LAWRENSON, R. A, DE VRIES, C. S

    Published in Diabetologia (01-12-2006)
    “…Risk estimates for stroke in patients with diabetes vary. We sought to obtain reliable risk estimates for stroke and the association with diabetes, comorbidity…”
    Get full text
    Journal Article
  5. 5

    Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database by Mulnier, H. E, Seaman, H. E, Raleigh, V. S, Soedamah-Muthu, S. S, Colhoun, H. M, Lawrenson, R. A, de Vries, C. S

    Published in Diabetologia (01-09-2008)
    “…Aims/hypothesis Our primary aim was to establish reliable and generalisable estimates of the risk of myocardial infarction (MI) for men and women with type 2…”
    Get full text
    Journal Article
  6. 6

    FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test by Cooper, J. A., Moss, S. M., Smith, S., Seaman, H. E., Taylor-Phillips, S., Parsons, N., Halloran, S. P.

    Published in Colorectal disease (01-07-2016)
    “…Worldwide, the guaiac faecal occult blood test (gFOBT) is being replaced with the more accurate faecal immunochemical test (FIT) for colorectal cancer (CRC)…”
    Get full text
    Journal Article
  7. 7

    The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case–control study by Seaman, H.E., Vries, C.S.de, Farmer, R.D.T.

    Published in Human reproduction (Oxford) (01-03-2003)
    “…BACKGROUND: Cyproterone acetate combined with ethinyl estradiol (CPA/EE) is licensed in the UK for the treatment of women with acne and hirsutism and is also a…”
    Get full text
    Journal Article
  8. 8

    Differences in the use of combined oral contraceptives amongst women with and without acne by Seaman, H.E., Vries, C.S.de, Farmer, R.D.T.

    Published in Human reproduction (Oxford) (01-03-2003)
    “…BACKGROUND: Cyproterone acetate combined with ethinyl estradiol (CPA/EE) provides a treatment option for women with acne, hirsutism or polycystic ovary…”
    Get full text
    Journal Article
  9. 9

    Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette®): observational studies using the UK General Practice Research Database by Seaman, H. E., de Vries, C. S., Farmer, R. D. T.

    Published in Pharmacoepidemiology and drug safety (01-07-2004)
    “…Purpose To derive risk estimates for venous thromboembolism (VTE) in women prescribed cyproterone acetate combined with ethinyloestradiol (CPA/EE), a drug…”
    Get full text
    Journal Article
  10. 10

    Liver damage associated with Minocycline use in acne: A systematic review of the published literature and pharmacovigilance data by LAWRENSON, Ross A, SEAMAN, Helen E, SUNDSTRÖM, Anders, WILLIAMS, Timothy J, FARMER, Richard D. T

    Published in Drug safety (01-10-2000)
    “…Minocycline is an antibacterial drug used in the treatment of acne. Concern has been expressed over the possibility of severe adverse reactions to minocycline,…”
    Get full text
    Journal Article
  11. 11

    The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD by Seaman, H. E., de Vries, C. S., Farmer, R. D. T.

    Published in Pharmacoepidemiology and drug safety (01-10-2003)
    “…Purpose To explore the risk of liver disorders associated with cyproterone acetate combined with ethinyloestradiol (CPA/EE). CPA/EE is licensed in the UK for…”
    Get full text
    Journal Article
  12. 12

    The Risk of Liver Damage Associated with Minocycline: A Comparative Study by Seaman, Helen E., Lawrenson, Ross A., Williams, Tim J., MacRae, Kenneth D., Farmer, Richard D. T.

    Published in Journal of clinical pharmacology (01-08-2001)
    “…Using the General Practice Research Database, the authors performed (1) a cohort analysis comparing the incidence of liver dysfunction in new users of…”
    Get full text
    Journal Article